Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Jan 27, 2023 1:48pm
126 Views
Post# 35250588

RE:RE:RE:RE:RE:RE:RE:RE:market CRAZYNESS

RE:RE:RE:RE:RE:RE:RE:RE:market CRAZYNESSRPINVESTOR1:

Good to hear from you....it has been a while.

Yes,
Strangley Lee Buckler announced this NR yesterday:

2023-01-26 10:51 ET - News Release
Mr. Lee Buckler reports

What role does he now have with the company ?   I think he still may be a Director as an appeasement to him being removed from the CEO position.  That way he still gets paid as a Director.

Yes I have the same feeling this is the last load up by the Insiders before things begin to happen over the next few months.  As I mentioned in my last post this sudden PP announcement may be linked with their trip to Japan where in the Twiiter post they said:

"We just arrived in Japan! We are meeting with multiple potential investors"

Possibly they found one large investor wanting in and is taking this entire 10,500,000 share PP.
The only silver lining for me is with all the big shareholders wanting more shares, something is up.....let's hope


<< Previous
Bullboard Posts
Next >>